The Biobanking and BioMolecular resources Research Infrastructure (BBMRI) is the European Research Infrastructure for Biobanking and Biomolecular Resources in health and life sciences. . Entered in the ESFRI Roadmap 2006, BBMRI became a European Research Infrastructure Consortium (ERIC) in December 2013. BBMRI brings together 25 members and observers, including an intergovernmental organisation: Members are Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Slovenia, Sweden, Switzerland and observers are Denmark, IARC/WHO, Qatar, Spain, and finally Turkey. Each member and observer has one National Node, which brings together the national communities in each country. BBMRI-ERIC is thus being one of the largest ERICs membership-wise. The core mission of BBMRI-ERIC embedded in its statutes is facilitating access to biobanks and biomolecular resources in collaboration with its National Nodes, aiming to improve the accessibility and interoperability of existing comprehensive collections, either population based or clinical-oriented, of biological samples from different (sub-)populations of Europe. Via its databases, BBMRI-ERIC connects around 400 biobanks, and close over 2600 collections across 32 countries, with 9,000 users in 2023. This makes BBMRI-ERIC the biggest biobank directory in the world. Besides strong IT service, BBMRI also offers quality management services (including co-creating of relevant standards though participation in ISO since 2015), does research and provides services in the area of ethical, legal and societal issues, and ensures smooth cooperation with its scientific community via its biobanking development services. BBMRI-ERIC is continuously expanding its membership and building partnerships with countries and biobanks in Europe and beyond. In this respect in 2022 BBMRI-ERIC put in place a Policy on membership of associated and third countries. This paved the way for Qatar becoming an observer in BBMRI-ERIC in 2022, based on a long-standing collaboration with the Qatar Biobank. Via its Stakeholder Forum, BBMRI fosters relations with Patient Organisations in its member and observer countries, as well as European level-organisations. In 2024 the Patient and Citizens pillar of BBMRI-ERIC brings together 26 patient organisations from 13 countries and European level one. Relations with industry are in focus on specific topics, such as cooperation for organisation of the European Biobank Week, which brings together about 700 members of the biobanking community on a yearly basis. Moreover, BBMRI-ERIC engages in a co-creation with industry partners on topic of greening in biobanking. BBMRI plays a vital role in structuring the European Research Area, by coordinating or participating in over 25 EU projects. Its engagement in projects are aligned with the overall EU policy priorities research and evolve around the EU Mission on cancer (e.g. CanSERV-coordination, EOSC4Cancer and UNCAN.eu), Beating Cancer Plan, EOSC (e.g., Corbel, EOSC-Life, EOSC Future, BBMRI membership of EOSC-A), Pandemic Preparedness (e.g., ISIDORe, BY-COVID, BBMRI-Directory), Personalised Medicine and Rare Disease Partnership, and the European Health Data Space (e.g. EHDS2 Pilot). In addition, BBMRI-ERIC is also coordinating the ERIC Forum project.